Gerber Kawasaki Wealth & Investment Management Kempharm, Inc Transaction History

Gerber Kawasaki Wealth & Investment Management

$2.28 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 11, 2022	SELL	$7.6 - $10.26 $7 - $10	-1 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.72 - $13.31 $8 - $13	1 New	1 $1,000

Others Institutions Holding KMPH

# of Institutions

115

Shares Held

30.2M

Call Options Held

284K

Put Options Held

24.1K

Woodline Partners LP San Francisco, CA

4.14M
Shares

$20.4 Million
0.15% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

3.65M
Shares

$18 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

2.82M
Shares

$14 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.7M
Shares

$13.3 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

2.34M
Shares

$11.6 Million
0.58% of portfolio

View Full List

About KEMPHARM, INC

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

More about KMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gerber Kawasaki Wealth & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Gerber Kawasaki Wealth & Investment Management with notifications on news.

Account